cefazolin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabral, SM; Cosgrove, SE; Goodman, KE; Harris, AD; Magder, LS; Tamma, PD | 1 |
1 other study(ies) available for cefazolin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries Across 825 US Hospitals, 2019-2020.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; COVID-19; Guideline Adherence; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Pandemics; Retrospective Studies; Surgical Wound Infection; Vancomycin | 2023 |